DrugPatentWatch Database Preview
CLINICAL TRIALS PROFILE FOR IMIPENEM AND CILASTATIN
» See Plans and Pricing
All Clinical Trials for Imipenem And Cilastatin
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00080496 | Study Evaluating Tigecycline Versus Imipenem/Cilastatin in Hospital-Acquired Pneumonia | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 3 | 2003-07-01 | To compare the efficacy and safety of the tigecycline regimen with that of the imipenem/cilastatin regimen in subjects with nosocomial pneumonia. |
| NCT00081744 | Study Comparing Tigecycline to Imipenem/Cilastatin in Complicated Intra-Abdominal Infections in Hospitalized Subjects | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 3 | 2002-11-01 | Purpose: To provide a mechanism for the emergency use of tigecycline in the appropriate clinical situations. |
| NCT00136201 | Study Comparing Tigecycline and Imipenem/Cilastatin in Chinese Subjects With Complicated Intra-Abdominal Infections | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 3 | 2005-11-01 |
The primary objective of this study is to compare the safety and efficacy of an experimental
antibiotic to a marketed antibiotic in the treatment of Chinese subjects with complicated
intra-abdominal infections. |
| NCT00236834 | A Study of the Safety and Effectiveness of Levofloxacin Compared With Imipenem/Cilastatin in Patients With Pneumonia Acquired During Hospitalization | Completed | PriCara, Unit of Ortho-McNeil, Inc. | Phase 3 | 1997-12-01 | The purpose of this study is to compare the safety and effectiveness of levofloxacin with imipenem/cilastatin in the treatment of hospital-acquired pneumonia |
| NCT00236834 | A Study of the Safety and Effectiveness of Levofloxacin Compared With Imipenem/Cilastatin in Patients With Pneumonia Acquired During Hospitalization | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Phase 3 | 1997-12-01 | The purpose of this study is to compare the safety and effectiveness of levofloxacin with imipenem/cilastatin in the treatment of hospital-acquired pneumonia |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Imipenem And Cilastatin
Condition Name
Clinical Trial Locations for Imipenem And Cilastatin
Trials by Country
Clinical Trial Progress for Imipenem And Cilastatin
Clinical Trial Phase
Clinical Trial Sponsors for Imipenem And Cilastatin
Sponsor Name
| Sponsor Name for Imipenem And Cilastatin | |
| Sponsor | Trials |
| Merck Sharp & Dohme Corp. | 12 |
| Wyeth is now a wholly owned subsidiary of Pfizer | 3 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 3 |
| [disabled in preview] | 4 |
| This preview shows a limited data set Subscribe for full access, or try a Trial | |
